Teladoc Health reported Q3 2024 revenue of $640.5 million, a 3% decrease year-over-year. Net loss was $33.3 million, or $0.19 per share. The Integrated Care segment saw revenue increase by 2%, while the BetterHelp segment experienced a 10% decrease.
Revenue decreased by 3% year-over-year to $640.5 million.
Net loss was $33.3 million, or $0.19 per share.
Adjusted EBITDA decreased by 6% year-over-year to $83.3 million.
Integrated Care segment revenue increased by 2%, while BetterHelp segment revenue decreased by 10%.
Teladoc Health provided financial outlook for the Integrated Care segment for Q4 2024.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance